Unraveling the Lab Diamond Conspiracy: Insights on Elephants and More
Hello everyone!
In the wild, elephants face a few predators, but their most significant threat is invisible: the Elephant Endotheliotropic Herpesvirus (EEHV). This virus primarily impacts Asian elephants, particularly vulnerable calves aged between one and eight years, although African elephants are also increasingly at risk.
Both Asian and African elephants are classified as ‘endangered’ on the IUCN Red List, making the threat of EEHV even more urgent. This viral infection leads to severe internal bleeding, and young elephants, with their immature immune systems, have a tragically low survival rate. For instance, between 2013 and 2019, a staggering 13 calves in South India succumbed to this virus.
What makes EEHV particularly hazardous is its unpredictability. The exact triggers for the virus to activate remain unclear, and in captive settings like zoos and elephant sanctuaries, infected calves often have only 24 to 48 hours before the situation becomes critical. Interestingly, adult elephants can carry the virus without any negative effects, allowing it to remain covert within herds.
Hope on the Horizon: Vaccine Developments
There’s renewed hope as recent vaccine trials show potential. Previously, there was no effective cure or preventative measure for EEHV; emergency care often fell short once symptoms arose. However, researchers have been diligently seeking solutions.
A team from the University of Surrey, in collaboration with the UK’s Animal and Plant Health Agency (APHA), initiated the first-ever EEHV vaccine trial at Chester Zoo, which has previously lost seven calves to the virus over the past decade. They tested the vaccine on three elephants and meticulously tracked their reactions and health before and after vaccination.
How the Vaccine Works
The innovative vaccine utilizes non-infectious proteins derived from the virus, allowing the elephant’s immune system to learn to detect and combat EEHV. The initial results were optimistic, showing successful production of T-cells—crucial defenders that target infected cells while also fostering long-term immunity. Remarkably, the vaccinated elephants did not exhibit any adverse effects, marking a significant milestone in addressing EEHV.
The current trial consists of four injections. If these preliminary successes are confirmed in broader field experiments, this breakthrough could safeguard future generations of elephants against the virus, potentially requiring fewer injections than previously thought. If all goes well, the next group of calves could thrive in a virus-free environment!
In the Spotlight: Trending Topics
What else has captured our attention this week? 💎
Are countries intentionally driving down lab-grown diamond prices? The price of lab-grown diamonds has experienced a dramatic drop recently, with reports noting an almost 96% decline in wholesale prices for one-carat and two-carat stones since 2018, mainly attributed to an overproduction from India and China.
Initially, LGDs (lab-grown diamonds) provided accessible options for consumers, encouraging shopping like never before. However, the sudden influx has created an oversupply that may be causing buyers to shift back towards natural diamonds, which still retain an emotional value tied to rarity.
A Strategic Play or Market Forces?
As the market rapidly evolves, major brands seem to have positioned themselves to benefit no matter which way consumers lean. For instance, Kalyan can maintain its luxury identity while leveraging brands like Candere to appeal to mid-range buyers. This dynamic strategy might make it seem like there’s a larger scheme at play.
Yet, whether intentional or not, the resulting interest in natural diamonds appears to be growing as people begin to acknowledge their diminishing availability. Or could it simply be the workings of the market? Perhaps we’re just overanalyzing the situation!
Engage With Us!
This week, we’re excited to share a recommended reading from our reader, Shaleen Kachhara: The Siege: 68 Hours Inside The Taj Hotel by Adrian Levy and Cathy Scott-Clark. It’s a gripping narrative detailing the 26/11 Mumbai attacks, with in-depth interviews and research from the authors.
That wraps up our updates for the week! If you have any book, music, or podcast recommendations, we’d love to hear from you. What do you think about the challenges elephants face or the changing landscape of diamond pricing? Share your thoughts with us!
🖖🏽
